VIVS
VivoSim Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.28
−0.29%1
Insider buys (3m)
0
Insider sells (3m)
$2.8K
Net value (3m)
-76.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Lialin Tony Serge · officer: Chief Commercial Officer | Purchase | 10,000 | $0.28 |
| Jan 29, 2026 | Murphy Keith · director, officer: EXECUTIVE CHAIRMAN | A-Award | 15,000 | $0.00 |
| Jan 29, 2026 | Milhous Alison Tjosvold · director | A-Award | 15,000 | $0.00 |
| Jan 29, 2026 | Gobel David · director | A-Award | 15,000 | $0.00 |
| Jan 29, 2026 | Cohen Douglas Jay · director | A-Award | 15,000 | $0.00 |
| Jan 29, 2026 | STERN ADAM K · director | A-Award | 15,000 | $0.00 |
| Nov 26, 2025 | Sethi Amar Akhtar · officer: Chief Scientific Officer | A-Award | 53,500 | $2.19 |
| Nov 19, 2025 | Gobel David · director | Sale | 3,266 | $2.24 |
| Aug 21, 2025 | Lialin Tony Serge · officer: Chief Commercial Officer | A-Award | 40,000 | $1.78 |
Institutional positioning
13F filings over the trailing two quarters
New 5Increased 4Reduced 3Sold out 24
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 36,850 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | New Position | 16,072 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 15,371 | May 15, 2026 |
| BLACKROCK, INC. | Unchanged | 11,817 | May 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 7,003 | May 8, 2026 |
| CITIGROUP INC | Increased | 6,504 | May 11, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Increased | 2,308 | May 15, 2026 |
| UBS GROUP AG | Increased | 952 | May 5, 2026 |
| SBI SECURITIES CO., LTD. | Unchanged | 221 | Apr 28, 2026 |
| ALLWORTH FINANCIAL LP | Unchanged | 208 | May 15, 2026 |
| LARSON FINANCIAL GROUP LLC | Unchanged | 166 | May 15, 2026 |
| ALBION FINANCIAL GROUP /UT | Unchanged | 159 | Apr 27, 2026 |
| WELLS FARGO & COMPANY/MN | Reduced | 111 | Jul 8, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | Unchanged | 95 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 50 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026